We use an array of cutting-edge scientific approaches, including unbiased large-scale screening methods, that uniquely allow for biology and disease to instruct us on relevant therapeutic targets. In addition, our distinctive methodologies increase significantly the efficiency with which our team develops innovative antibody therapies that can rapidly enter the clinic to benefit patients.